// App-Quantinova.ai

[SAT0396] : ANTI-ANNEXIN II: A NOVEL MARKER IN ANTIPHOSPHOLIPID SYNDROME

Researchers

Presenter

  • E. Soliman

Principal Investigators

  • A. Algerby

  • N. Mohannad

Medical Centers

  • Internal Medicine, Endocrinology, Alexandria Faculty of Medicine, Alexandria, Egypt

Locations

  • Egypt

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Antiphospholipid syndrome

  • Venous thrombosis

  • Lupus

Biomarkers

  • Immunoglobulin G

  • Lactate

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim